APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Detection Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tumor Detection Services Market Analysis and Forecast 2026-2032

5 June 2026250 pages

Choose your research edition.

Industry ResearchTumor Detection Services Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Detection Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Tumor Detection Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Detection Services Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Detection Services Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

The global Tumor Detection Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Tumor Detection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tumor Detection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tumor Detection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tumor Detection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Tumor Detection Services include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta and Bio-Techne, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Tumor Detection Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tumor Detection Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Tumor Detection Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tumor Detection Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tumor Detection Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Tumor Detection Services revenue, projected growth trends, production technology, application and end-user industry.

Tumor Detection Services Segment by Company

Nonacus

Natera

Penn Medicine

Amadix

Oncologica

Rarecells

GRAIL

Elypta

Bio-Techne

iCAD

Dxcover

Caris Life Sciences

Novocure

Circulogene

Guardant Health

Veracyte

Haystack Oncology

Foundation Medicine

Tumor Detection Services Segment by Type

Non-Invasive Examination

Invasive Examination

Tumor Detection Services Segment by Application

Adults

Children

Tumor Detection Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Detection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Detection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Detection Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Tumor Detection Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Tumor Detection Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Detection Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Detection Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-Invasive Examination Major Player Table 3. Invasive Examination Major Player Table 4. Global Tumor Detection Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adults Major Player Table 6. Children Major Player Table 7. Tumor Detection Services Industry Trends Table 8. Tumor Detection Services Industry Drivers Table 9. Tumor Detection Services Industry Opportunities and Challenges Table 10. Tumor Detection Services Industry Restraints Table 11. Global Tumor Detection Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Tumor Detection Services Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Tumor Detection Services Market Share by Region (2021-2026) Table 14. Global Tumor Detection Services Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Tumor Detection Services Market Share by Region (2027-2032) Table 16. Global Tumor Detection Services Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Tumor Detection Services Revenue Market Share by Players (2021-2026) Table 18. Global Tumor Detection Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Tumor Detection Services Key Players Headquarters & Area Served Table 20. Global Tumor Detection Services Players, Product Type & Application Table 21. Global Tumor Detection Services Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Tumor Detection Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Tumor Detection Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Tumor Detection Services Revenue Market Share by Type (2021-2026) Table 28. Global Tumor Detection Services Revenue Market Share by Type (2027-2032) Table 29. Global Tumor Detection Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Tumor Detection Services Revenue Market Share by Application (2021-2026) Table 33. Global Tumor Detection Services Revenue Market Share by Application (2027-2032) Table 34. Nonacus Company Information Table 35. Nonacus Business Overview Table 36. Nonacus Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Nonacus Tumor Detection Services Product Portfolio Table 38. Nonacus Recent Development Table 39. Natera Company Information Table 40. Natera Business Overview Table 41. Natera Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Natera Tumor Detection Services Product Portfolio Table 43. Natera Recent Development Table 44. Penn Medicine Company Information Table 45. Penn Medicine Business Overview Table 46. Penn Medicine Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Penn Medicine Tumor Detection Services Product Portfolio Table 48. Penn Medicine Recent Development Table 49. Amadix Company Information Table 50. Amadix Business Overview Table 51. Amadix Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Amadix Tumor Detection Services Product Portfolio Table 53. Amadix Recent Development Table 54. Oncologica Company Information Table 55. Oncologica Business Overview Table 56. Oncologica Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Oncologica Tumor Detection Services Product Portfolio Table 58. Oncologica Recent Development Table 59. Rarecells Company Information Table 60. Rarecells Business Overview Table 61. Rarecells Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Rarecells Tumor Detection Services Product Portfolio Table 63. Rarecells Recent Development Table 64. GRAIL Company Information Table 65. GRAIL Business Overview Table 66. GRAIL Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GRAIL Tumor Detection Services Product Portfolio Table 68. GRAIL Recent Development Table 69. Elypta Company Information Table 70. Elypta Business Overview Table 71. Elypta Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Elypta Tumor Detection Services Product Portfolio Table 73. Elypta Recent Development Table 74. Bio-Techne Company Information Table 75. Bio-Techne Business Overview Table 76. Bio-Techne Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Bio-Techne Tumor Detection Services Product Portfolio Table 78. Bio-Techne Recent Development Table 79. iCAD Company Information Table 80. iCAD Business Overview Table 81. iCAD Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. iCAD Tumor Detection Services Product Portfolio Table 83. iCAD Recent Development Table 84. Dxcover Company Information Table 85. Dxcover Business Overview Table 86. Dxcover Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Dxcover Tumor Detection Services Product Portfolio Table 88. Dxcover Recent Development Table 89. Caris Life Sciences Company Information Table 90. Caris Life Sciences Business Overview Table 91. Caris Life Sciences Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Caris Life Sciences Tumor Detection Services Product Portfolio Table 93. Caris Life Sciences Recent Development Table 94. Novocure Company Information Table 95. Novocure Business Overview Table 96. Novocure Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Novocure Tumor Detection Services Product Portfolio Table 98. Novocure Recent Development Table 99. Circulogene Company Information Table 100. Circulogene Business Overview Table 101. Circulogene Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Circulogene Tumor Detection Services Product Portfolio Table 103. Circulogene Recent Development Table 104. Guardant Health Company Information Table 105. Guardant Health Business Overview Table 106. Guardant Health Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Guardant Health Tumor Detection Services Product Portfolio Table 108. Guardant Health Recent Development Table 109. Veracyte Company Information Table 110. Veracyte Business Overview Table 111. Veracyte Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Veracyte Tumor Detection Services Product Portfolio Table 113. Veracyte Recent Development Table 114. Haystack Oncology Company Information Table 115. Haystack Oncology Business Overview Table 116. Haystack Oncology Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Haystack Oncology Tumor Detection Services Product Portfolio Table 118. Haystack Oncology Recent Development Table 119. Foundation Medicine Company Information Table 120. Foundation Medicine Business Overview Table 121. Foundation Medicine Tumor Detection Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Foundation Medicine Tumor Detection Services Product Portfolio Table 123. Foundation Medicine Recent Development Table 124. North America Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Tumor Detection Services Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Tumor Detection Services Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Tumor Detection Services Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Tumor Detection Services Revenue by Country (US$ Million) & (2027-2032) Table 138. China Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 139. China Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 140. China Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 141. China Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Tumor Detection Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Tumor Detection Services Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Tumor Detection Services Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Tumor Detection Services Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Tumor Detection Services Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Tumor Detection Services Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Tumor Detection Services Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Tumor Detection Services Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Tumor Detection Services Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Tumor Detection Services Image Figure 2. Global Tumor Detection Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Detection Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-Invasive Examination Image Figure 5. Invasive Examination Image Figure 6. Global Tumor Detection Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tumor Detection Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adults Image Figure 9. Children Image Figure 10. Global Tumor Detection Services Market Size (US$ Million) & (2021-2032) Figure 11. Global Tumor Detection Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tumor Detection Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Tumor Detection Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Tumor Detection Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Tumor Detection Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Tumor Detection Services Revenue Market Share by Type (2021-2032) Figure 18. Global Tumor Detection Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Tumor Detection Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Tumor Detection Services Revenue Market Share by Application (2021-2032) Figure 21. North America Tumor Detection Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Tumor Detection Services Revenue Share by Type (2021-2032) Figure 23. North America Tumor Detection Services Revenue Share by Application (2021-2032) Figure 24. North America Tumor Detection Services Revenue Share by Country (2021-2032) Figure 25. United States Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Tumor Detection Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Tumor Detection Services Revenue Share by Type (2021-2032) Figure 30. Europe Tumor Detection Services Revenue Share by Application (2021-2032) Figure 31. Europe Tumor Detection Services Revenue Share by Country (2021-2032) Figure 32. Germany Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Tumor Detection Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Tumor Detection Services Revenue Share by Type (2021-2032) Figure 42. China Tumor Detection Services Revenue Share by Application (2021-2032) Figure 43. Asia Tumor Detection Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Tumor Detection Services Revenue Share by Type (2021-2032) Figure 45. Asia Tumor Detection Services Revenue Share by Application (2021-2032) Figure 46. Asia Tumor Detection Services Revenue Share by Region (2021-2032) Figure 47. Japan Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Tumor Detection Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Tumor Detection Services Revenue Share by Type (2021-2032) Figure 55. SAMEA Tumor Detection Services Revenue Share by Application (2021-2032) Figure 56. SAMEA Tumor Detection Services Revenue Share by Country (2021-2032) Figure 57. Brazil Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Tumor Detection Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Invasive Examination
  • Invasive Examination
Applications
  • Adults
  • Children
Companies covered
  • Nonacus
  • Natera
  • Penn Medicine
  • Amadix
  • Oncologica
  • Rarecells
  • GRAIL
  • Elypta
  • Bio-Techne
  • iCAD
  • Dxcover
  • Caris Life Sciences
  • Novocure
  • Circulogene
  • Guardant Health
  • Veracyte
  • Haystack Oncology
  • Foundation Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tumor Detection Services Market by Type
  3. 1.2.1 Global Tumor Detection Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-Invasive Examination
  5. 1.2.3 Invasive Examination
  6. 1.3 Tumor Detection Services Market by Application
  7. 1.3.1 Global Tumor Detection Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adults
  9. 1.3.3 Children
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Tumor Detection Services Market Dynamics
  1. 2.1 Tumor Detection Services Industry Trends
  2. 2.2 Tumor Detection Services Industry Drivers
  3. 2.3 Tumor Detection Services Industry Opportunities and Challenges
  4. 2.4 Tumor Detection Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Tumor Detection Services Market Perspective (2021-2032)
  2. 3.2 Global Tumor Detection Services Growth Trends by Region
  3. 3.2.1 Global Tumor Detection Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tumor Detection Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Tumor Detection Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Tumor Detection Services Revenue by Players
  2. 4.1.1 Global Tumor Detection Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Tumor Detection Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Tumor Detection Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tumor Detection Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Tumor Detection Services Key Players Headquarters & Area Served
  7. 4.4 Global Tumor Detection Services Players, Product Type & Application
  8. 4.5 Global Tumor Detection Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Tumor Detection Services Market CR5 and HHI
  11. 4.6.3 2025 Tumor Detection Services Tier 1, Tier 2, and Tier 3
5 Tumor Detection Services Market Size by Type
  1. 5.1 Global Tumor Detection Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Detection Services Revenue by Type (2021-2032)
  3. 5.3 Global Tumor Detection Services Revenue Market Share by Type (2021-2032)
6 Tumor Detection Services Market Size by Application
  1. 6.1 Global Tumor Detection Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Tumor Detection Services Revenue by Application (2021-2032)
  3. 6.3 Global Tumor Detection Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Nonacus
  2. 7.1.1 Nonacus Company Information
  3. 7.1.2 Nonacus Business Overview
  4. 7.1.3 Nonacus Tumor Detection Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Nonacus Tumor Detection Services Product Portfolio
  6. 7.1.5 Nonacus Recent Developments
  7. 7.2 Natera
  8. 7.2.1 Natera Company Information
  9. 7.2.2 Natera Business Overview
  10. 7.2.3 Natera Tumor Detection Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Natera Tumor Detection Services Product Portfolio
  12. 7.2.5 Natera Recent Developments
  13. 7.3 Penn Medicine
  14. 7.3.1 Penn Medicine Company Information
  15. 7.3.2 Penn Medicine Business Overview
  16. 7.3.3 Penn Medicine Tumor Detection Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Penn Medicine Tumor Detection Services Product Portfolio
  18. 7.3.5 Penn Medicine Recent Developments
  19. 7.4 Amadix
  20. 7.4.1 Amadix Company Information
  21. 7.4.2 Amadix Business Overview
  22. 7.4.3 Amadix Tumor Detection Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Amadix Tumor Detection Services Product Portfolio
  24. 7.4.5 Amadix Recent Developments
  25. 7.5 Oncologica
  26. 7.5.1 Oncologica Company Information
  27. 7.5.2 Oncologica Business Overview
  28. 7.5.3 Oncologica Tumor Detection Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Oncologica Tumor Detection Services Product Portfolio
  30. 7.5.5 Oncologica Recent Developments
  31. 7.6 Rarecells
  32. 7.6.1 Rarecells Company Information
  33. 7.6.2 Rarecells Business Overview
  34. 7.6.3 Rarecells Tumor Detection Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Rarecells Tumor Detection Services Product Portfolio
  36. 7.6.5 Rarecells Recent Developments
  37. 7.7 GRAIL
  38. 7.7.1 GRAIL Company Information
  39. 7.7.2 GRAIL Business Overview
  40. 7.7.3 GRAIL Tumor Detection Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GRAIL Tumor Detection Services Product Portfolio
  42. 7.7.5 GRAIL Recent Developments
  43. 7.8 Elypta
  44. 7.8.1 Elypta Company Information
  45. 7.8.2 Elypta Business Overview
  46. 7.8.3 Elypta Tumor Detection Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Elypta Tumor Detection Services Product Portfolio
  48. 7.8.5 Elypta Recent Developments
  49. 7.9 Bio-Techne
  50. 7.9.1 Bio-Techne Company Information
  51. 7.9.2 Bio-Techne Business Overview
  52. 7.9.3 Bio-Techne Tumor Detection Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bio-Techne Tumor Detection Services Product Portfolio
  54. 7.9.5 Bio-Techne Recent Developments
  55. 7.10 iCAD
  56. 7.10.1 iCAD Company Information
  57. 7.10.2 iCAD Business Overview
  58. 7.10.3 iCAD Tumor Detection Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 iCAD Tumor Detection Services Product Portfolio
  60. 7.10.5 iCAD Recent Developments
  61. 7.11 Dxcover
  62. 7.11.1 Dxcover Company Information
  63. 7.11.2 Dxcover Business Overview
  64. 7.11.3 Dxcover Tumor Detection Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Dxcover Tumor Detection Services Product Portfolio
  66. 7.11.5 Dxcover Recent Developments
  67. 7.12 Caris Life Sciences
  68. 7.12.1 Caris Life Sciences Company Information
  69. 7.12.2 Caris Life Sciences Business Overview
  70. 7.12.3 Caris Life Sciences Tumor Detection Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Caris Life Sciences Tumor Detection Services Product Portfolio
  72. 7.12.5 Caris Life Sciences Recent Developments
  73. 7.13 Novocure
  74. 7.13.1 Novocure Company Information
  75. 7.13.2 Novocure Business Overview
  76. 7.13.3 Novocure Tumor Detection Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Novocure Tumor Detection Services Product Portfolio
  78. 7.13.5 Novocure Recent Developments
  79. 7.14 Circulogene
  80. 7.14.1 Circulogene Company Information
  81. 7.14.2 Circulogene Business Overview
  82. 7.14.3 Circulogene Tumor Detection Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Circulogene Tumor Detection Services Product Portfolio
  84. 7.14.5 Circulogene Recent Developments
  85. 7.15 Guardant Health
  86. 7.15.1 Guardant Health Company Information
  87. 7.15.2 Guardant Health Business Overview
  88. 7.15.3 Guardant Health Tumor Detection Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Guardant Health Tumor Detection Services Product Portfolio
  90. 7.15.5 Guardant Health Recent Developments
  91. 7.16 Veracyte
  92. 7.16.1 Veracyte Company Information
  93. 7.16.2 Veracyte Business Overview
  94. 7.16.3 Veracyte Tumor Detection Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Veracyte Tumor Detection Services Product Portfolio
  96. 7.16.5 Veracyte Recent Developments
  97. 7.17 Haystack Oncology
  98. 7.17.1 Haystack Oncology Company Information
  99. 7.17.2 Haystack Oncology Business Overview
  100. 7.17.3 Haystack Oncology Tumor Detection Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Haystack Oncology Tumor Detection Services Product Portfolio
  102. 7.17.5 Haystack Oncology Recent Developments
  103. 7.18 Foundation Medicine
  104. 7.18.1 Foundation Medicine Company Information
  105. 7.18.2 Foundation Medicine Business Overview
  106. 7.18.3 Foundation Medicine Tumor Detection Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Foundation Medicine Tumor Detection Services Product Portfolio
  108. 7.18.5 Foundation Medicine Recent Developments
8 North America
  1. 8.1 North America Tumor Detection Services Revenue (2021-2032)
  2. 8.2 North America Tumor Detection Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Tumor Detection Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Tumor Detection Services Revenue by Type (2027-2032)
  5. 8.3 North America Tumor Detection Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Tumor Detection Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Tumor Detection Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Tumor Detection Services Revenue by Application (2027-2032)
  9. 8.5 North America Tumor Detection Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Tumor Detection Services Revenue by Country
  11. 8.6.1 North America Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Tumor Detection Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Tumor Detection Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Tumor Detection Services Revenue (2021-2032)
  2. 9.2 Europe Tumor Detection Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Tumor Detection Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Tumor Detection Services Revenue by Type (2027-2032)
  5. 9.3 Europe Tumor Detection Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Tumor Detection Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Tumor Detection Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Tumor Detection Services Revenue by Application (2027-2032)
  9. 9.5 Europe Tumor Detection Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Tumor Detection Services Revenue by Country
  11. 9.6.1 Europe Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Tumor Detection Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Tumor Detection Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Tumor Detection Services Revenue (2021-2032)
  2. 10.2 China Tumor Detection Services Revenue by Type (2021-2032)
  3. 10.2.1 China Tumor Detection Services Revenue by Type (2021-2026)
  4. 10.2.2 China Tumor Detection Services Revenue by Type (2027-2032)
  5. 10.3 China Tumor Detection Services Revenue Share by Type (2021-2032)
  6. 10.4 China Tumor Detection Services Revenue by Application (2021-2032)
  7. 10.4.1 China Tumor Detection Services Revenue by Application (2021-2026)
  8. 10.4.2 China Tumor Detection Services Revenue by Application (2027-2032)
  9. 10.5 China Tumor Detection Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tumor Detection Services Revenue (2021-2032)
  2. 11.2 Asia Tumor Detection Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Tumor Detection Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Tumor Detection Services Revenue by Type (2027-2032)
  5. 11.3 Asia Tumor Detection Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Tumor Detection Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Tumor Detection Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Tumor Detection Services Revenue by Application (2027-2032)
  9. 11.5 Asia Tumor Detection Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Tumor Detection Services Revenue by Country
  11. 11.6.1 Asia Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Tumor Detection Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Tumor Detection Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tumor Detection Services Revenue (2021-2032)
  2. 12.2 SAMEA Tumor Detection Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Tumor Detection Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Tumor Detection Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Tumor Detection Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Tumor Detection Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Tumor Detection Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Tumor Detection Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Tumor Detection Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Tumor Detection Services Revenue by Country
  11. 12.6.1 SAMEA Tumor Detection Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Tumor Detection Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Tumor Detection Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst